Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer

被引:217
作者
Jones, C
Mackay, A
Grigoriadis, A
Cossu, A
Reis-Filho, JS
Fulford, L
Dexter, T
Davies, S
Bulmer, K
Ford, E
Parry, S
Budroni, M
Palmieri, G
Neville, AM
O'Hare, MJ
Lakhani, SR
机构
[1] Inst Canc Res, Breakthrough Toby Robins Breast Canc Res, London SW3 6JB, England
[2] UCL, Breast Canc Lab, Ludwig Inst Canc Res, London, England
[3] Univ Sassari, Inst Anat Patol, I-07100 Sassari, Italy
[4] UCL, Ludwig Inst Canc Res, London, England
[5] Ist Chim Biomol, Alghero, Italy
[6] Serv Epidemiol, Sassari, Italy
[7] Royal Marsden Hosp, London SW3 6JJ, England
关键词
D O I
10.1158/0008-5472.CAN-03-2028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The normal duct-lobular system of the breast is lined by two epithelial cell types, inner luminal secretory cells and outer contractile myoepithelial cells. We have generated comprehensive expression profiles of the two normal cell types, using immunomagnetic cell separation and gene expression microarray analysis. The cell-type specificity was confirmed at the protein level by immunohistochemistry in normal breast tissue. New prognostic markers for survival were identified when the luminal- and myoepithelial-specific molecules were evaluated on breast tumor tissue microarrays. Nuclear expression of luminal epithelial marker galectin 3 correlated with a shorter overall survival in these patients, and the expression of SPARC (osteonectin), a myoepithelial marker, was an independent marker of poor prognosis in breast cancers as a whole. These data provide a framework for the interpretation of breast cancer molecular profiling experiments, the identification of potential new diagnostic markers, and development of novel indicators of prognosis.
引用
收藏
页码:3037 / 3045
页数:9
相关论文
共 40 条
[11]  
DiRenzo J, 2002, CANCER RES, V62, P89
[12]   Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer [J].
Försti, A ;
Louhelainen, J ;
Söderberg, M ;
Wijkström, H ;
Hemminki, K .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (11) :1372-1380
[13]  
GOULD VE, 1990, AM J PATHOL, V137, P1143
[14]  
GUSTERSON BA, 1982, CANCER RES, V42, P4763
[15]   Gene expression predictors of breast cancer outcomes [J].
Huang, E ;
Cheng, SH ;
Dressman, H ;
Pittman, J ;
Tsou, MH ;
Horng, CF ;
Bild, A ;
Iversen, ES ;
Liao, M ;
Chen, CM ;
West, M ;
Nevins, JR ;
Huang, AT .
LANCET, 2003, 361 (9369) :1590-1596
[16]   CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation [J].
Jones, C ;
Nonni, AV ;
Fulford, L ;
Merrett, S ;
Chaggar, R ;
Eusebi, V ;
Lakhani, SR .
BRITISH JOURNAL OF CANCER, 2001, 85 (03) :422-427
[17]   Tissue microarrays for high-throughput molecular profiling of tumor specimens [J].
Kononen, J ;
Bubendorf, L ;
Kallioniemi, A ;
Bärlund, M ;
Schraml, P ;
Leighton, S ;
Torhorst, J ;
Mihatsch, MJ ;
Sauter, G ;
Kallioniemi, OP .
NATURE MEDICINE, 1998, 4 (07) :844-847
[18]  
Lakhani SR, 1999, J PATHOL, V189, P496, DOI 10.1002/(SICI)1096-9896(199912)189:4&lt
[19]  
496::AID-PATH485&gt
[20]  
3.0.CO